@inproceedings{inproceedings, title = {{Efficacy and safety of abrocitinib in patients with moderate-to-severe atopic dermatitis: results from the phase III, JADE MONO-1 study}}, url = {{}}, year = {{2020}}, month = {{1}}, author = {{Simpson EL and Sinclair R and Forman S and Wollenberg A and Asch R and Cork M and Bieber T and Thyssen JP and Yosipovitch G and Magnolo N and Maari C et al}}, volume = {{183}}, journal = {{BRITISH JOURNAL OF DERMATOLOGY}}, issue = {{4}}, pages = {{E105-E106}}, note = {{Accessed on 2024/12/22}}}